← Back to headlines
Oncotelic Therapeutics Reports GAAP EPS of $0.59
Oncotelic Therapeutics has announced its Generally Accepted Accounting Principles (GAAP) earnings per share (EPS) at $0.59.
16 Apr, 12:46 — 16 Apr, 12:46
Sources
Showing 1 of 1 sources
